Clinical TrialsSearch results
Number of results: 64596
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- XELOX(+bevacizumab), efficacy, safety, QOL Study:FOLFOX(+bevacizumab) after starting therapy, for patients can't continue continuous infusion therapy
- advanced and recurrent colorectal cancer
- Kochi Health Sciences Center
- 2010-07-28
Other
- XELOX plus PSK compared with XELOX as adjuvant treatment for StageIII colon cancer.
- colon cancer
- Showa University Northern Yokohama Hospital
- 2012-02-15
Other
- XELODA Special Drug Use Surveillance, XELOX as adjuvant chemotherapy for colon cancer
- colon cancer
- Chugai Pharmaceutical Co. Ltd.
- 2015-02-09
Other
- XED-60 in the treatment of dry eye, Phase2 study.
- Dry eye
- Lion Corporation
- 2015-03-03
Other
- WT1-antigen specific TCR-gene transduced T lymphocytes transfer using MS3-WT1-siTCR vector for acute myelogeneous leukemia and myelodysplastic syndrome
- acute myelogenous leukemia, myelodysplastic syndrome
- Mie University, Ehime University, Fujita Health University, Nagoya University, Takara Bio Inc.
- 2013-08-19
Other
- WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreatic and biliary tract cancers
- advanced pancreatic and biliary tract cancers
- Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine
- 2010-08-21
Other
- WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancer
- pancreas cancer
- Department of Cancer immunotherapy, Osaka University Medical School
- 2008-06-20
Other
- WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancer
- pancreas cancer
- Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine
- 2008-06-26
Other
- WT1 peptide-based cancer vaccine combined with gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a randomised, multicenter, phase 2 clinical study
- Pancreatic cancer
- Department of Cancer Immunotherapy, Osaka university Graduate school of Medicine
- 2011-04-01
Other
- WT1 peptide vaccine study after "Adoptive transfer of lymphocytes transduced with WT1-specific TCR gene"
- Acute myelogeous lekemia, Myelodysplastic syndrome
- Mie University Graduate School of Medicine
- 2015-05-06